药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tazarotene
Iloperidone
The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Iloperidone.
Tazarotene
Eliglustat
The risk or severity of QTc prolongation can be increased when Eliglustat is combined with Arsenic trioxide.
Tazarotene
Terodiline
The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Terodiline.
Tazarotene
Macimorelin
The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Macimorelin.
Tazarotene
Deutetrabenazine
The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Deutetrabenazine.
Tazarotene
Glasdegib
The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Glasdegib.
Tazarotene
Ribociclib
The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Ribociclib.
Tazarotene
Ivabradine
The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Ivabradine.
Tazarotene
Lumefantrine
The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Lumefantrine.
Tazarotene
Artemether
The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Artemether.
Tazarotene
Asenapine
The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Asenapine.
Tazarotene
Romidepsin
The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Romidepsin.
Tazarotene
Vandetanib
The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Vandetanib.
Tazarotene
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Tetrabenazine.
Tazarotene
Zuclopenthixol
The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Zuclopenthixol.
Tazarotene
Temafloxacin
The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Temafloxacin.
Tazarotene
Lithium cation
The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Lithium cation.
Tazarotene
Paliperidone
The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Paliperidone.
Tazarotene
Bepridil
The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Bepridil.
Tazarotene
Halofantrine
The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Halofantrine.